Everest Organics logo

Everest Organics

EVERESTORGANICSLTD NSE

Key Fundamentals

MicrocapPharmaceuticalsHealthcare
Market Cap
₹264 Cr
Volatility
Moderate
P/E Ratio
52.2
EBITDA
₹19.81 Cr
Return on Equity
-1.84%
Debt to Equity
0.66
Book Value
₹79.69
EPS
₹0.17
52W High
₹536.4
52W Low
₹197

Tapetide Score

Data-driven rating, 0–100. How it works →

Key Insights

Weaknesses

5
  • Stock is trading at 3.41 times its book value
  • The company has delivered a poor sales growth of 1.56% over past five years.
  • Company has a low return on equity of 2.49% over last 3 years.
  • Company has high debtors of 216 days.
  • Promoter holding has decreased over last 3 years: -14.6%

Growth Rate

Revenue Growth
22.45% higher than 3Y
Net Income Growth
-545% lower than 3Y
Cash Flow Change
-133% lower than 3Y
ROE
-713% lower than 3Y
ROCE
-74.78% lower than 3Y
EBITDA Margin (Avg.)
103% higher than 3Y

Quarterly Results

Particulars Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
42.67
49.45
52.51
52.62
32.45
44.05
42.05
40.93
53.81
51
42.59
48.75
48.43
Expenses
40.15
46.74
49.71
49.67
36.11
40.62
38.03
37.49
49.37
45.87
39.05
42.05
44.1
Operating Profit
2.52
2.71
2.8
2.95
-3.66
3.43
4.02
3.44
4.44
5.13
3.54
6.7
4.33
OPM %
5.91%
5.48%
5.33%
5.61%
-11.28%
7.79%
9.56%
8.4%
8.25%
10.06%
8.31%
13.74%
8.94%
Other Income
0.22
0.24
0.13
0.3
0.33
0.14
0
0.22
0.55
0.29
0.25
0.16
0.42
Interest
1.29
1.49
1.45
1.24
1.29
1.35
1.4
1.15
1.31
1.23
1.23
2.76
1.63
Depreciation
1.29
1.32
1.33
1.85
1.47
1.47
1.47
1.56
1.52
1.52
1.52
1.93
1.59
PBT
0.16
0.14
0.15
0.16
-6.09
0.75
1.15
0.95
2.16
2.67
1.04
2.17
1.53
Tax %
75%
78.57%
93.33%
62.5%
0%
1.33%
0.87%
-206.32%
35.19%
56.93%
65.38%
-21.2%
26.8%
Net Profit
0.04
0.03
0.02
0.06
-6.09
0.74
1.14
2.91
1.41
1.16
0.36
2.63
1.11
EPS in Rs
0.05
0.04
0.02
0.08
-7.61
0.92
1.42
3
1.45
1.19
0.37
2.71
1.14
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
106
99
107
112
156
167
182
200
183
197
159
196
191
Expenses
98
94
101
105
138
148
159
194
182
186
152
176
171
Operating Profit
8
6
6
7
18
19
23
6
1
11
7
20
20
OPM %
7%
6%
6%
6%
11%
11%
13%
3.2%
0.5%
6%
4.5%
10%
10%
Other Income
0
0
1
1
1
1
1
2
7
1
1
1
1
Interest
3
3
3
3
3
3
3
3
3
5
5
7
7
Depreciation
3
3
2
3
3
3
3
4
4
6
6
6
7
PBT
2
0
2
2
12
14
17
2
0
1
-3
8
7
Tax %
20%
18%
24%
28%
39%
23%
21%
34%
311%
77%
-60%
31%
—
Net Profit
2
0
1
2
8
11
14
1
0
0
-1
6
5
EPS in Rs
—
0.54
1.69
2.14
9.39
13.62
17.15
1.42
-0.22
0.18
-1.33
5.72
5.41
Div. Payout %
0%
0%
0%
0%
11%
7%
9%
0%
0%
0%
0%
0%
—
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
9
3
8
8
8
8
8
8
8
8
10
10
Reserves
-3
3
8
11
18
26
39
39
38
38
60
66
Borrowings
24
28
19
22
21
18
23
39
51
58
48
50
Other Liabilities
37
42
51
54
60
68
66
92
105
123
107
114
Total Liabilities
67
76
86
94
107
120
135
178
202
227
224
240
Fixed Assets
24
27
33
34
38
39
44
49
54
52
50
48
CWIP
0
1
1
1
0
1
0
8
12
21
23
21
Investments
0
0
0
0
0
0
0
0
0
0
0
0
Other Assets
42
47
52
60
68
80
92
121
136
153
152
171
Total Assets
67
76
86
94
107
120
135
178
202
227
224
240
Figures in ₹ Crores

Cash Flow

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
4
7
10
5
9
10
14
14
18
16
-5
4
Investing
-3
-7
-8
-4
-5
-6
-12
-17
-16
-13
-5
-2
Financing
-2
0
-2
-1
-3
-3
-2
2
-3
-3
16
-8
Net Cash Flow
0
0
0
0
1
0
0
-1
0
0
6
-6
Free Cash Flow
1
0
2
1
2
3
7
-3
5
3
-11
2
CFO/OP
52
119
162
64
50
51
59
214
1,981
149
-76
21
Figures in ₹ Crores

Ratios

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
100
117
105
124
95
97
102
125
152
185
202
216
Inventory Days
44
55
73
72
71
102
110
110
139
128
166
133
Days Payable
184
235
260
251
190
211
183
212
282
324
351
264
Cash Conversion Cycle
-40
-63
-83
-55
-24
-12
29
24
9
-11
17
85
Working Capital Days
-30
-38
-50
-34
-15
7
21
9
-12
-20
3
27
ROCE %
19%
11%
13%
13%
35%
35%
34%
6%
4%
6%
2%
12%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Everest Organics insights

64 extracted metrics + investor summaries across FY10–FY26.

Log in — free

Shareholding Pattern

DIIs0.02%Promot.59.60%Others13.42%Public26.95%As ofJun 2026

Documents

Frequently Asked Questions about Everest Organics

What does Everest Organics Ltd do?
Everest Organics Ltd (EOL) makes active pharmaceutical ingredients (APIs), the main medicinal ingredients in finished medicines, and chemical intermediates used to make APIs. Its factory is at Aroor, Sangareddy, Telangana.[1]
Where is Everest Organics Ltd (524790) listed?
Everest Organics Ltd trades as EVERESTORGANICSLTD on the NSE and under code EVERESTO on the BSE.
Which sector does Everest Organics Ltd belong to?
Everest Organics Ltd is classified under the Healthcare sector, in the Pharmaceuticals industry.
What is the market capitalisation of Everest Organics Ltd?
Everest Organics Ltd has a market capitalisation of ₹264.38 Cr, which places it in the Small Cap band.
What is the PE ratio of Everest Organics Ltd?
Everest Organics Ltd trades at a PE ratio of 52.20, on earnings per share of ₹0.17, against a book value of ₹79.69 per share.
What is the 52-week high and low of Everest Organics Ltd?
Over the last 52 weeks Everest Organics Ltd has traded between ₹197 and ₹536.4.
Does Everest Organics Ltd pay dividends?
Everest Organics Ltd has a dividend yield of 0.18%.
What is the Return on Equity (ROE) of Everest Organics Ltd?
Everest Organics Ltd reported a return on equity of -1.84%. Its debt-to-equity ratio is 0.66.

Company Information

Everest Organics Ltd (EOL) makes active pharmaceutical ingredients (APIs), the main medicinal ingredients in finished medicines, and chemical intermediates used to make APIs. Its factory is at Aroor, Sangareddy, Telangana.[1]

Website everestorganicsltd.com
Face Value ₹ 10

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/524790.md for Everest Organics Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our MCP server.

Explore More

More in Healthcare → FII DII Data Stock Screener Nifty 50 Heatmap F&O Ban List